臓器保存市場：保存ソリューション、臓器タイプ、技術、エンドユーザー別-2025～2030年の世界予測

臓器保存市場は、2023年に5億393万米ドルと評価され、2024年には5億4,148万米ドルに達すると予測され、CAGR 7.72%で成長し、2030年には8億4,857万米ドルに達すると予測されています。

臓器保存とは、臓器を切除してから移植するまでの間に臓器を保存し、移植を成功させるために臓器が生存し続けるように設計された一連の医療行為を指します。臓器保存の必要性は、臓器移植における需要と供給の決定的な格差に起因しており、タイムリーで効果的な保存技術によって臓器の生存能力を高め、無数の命を救う可能性があります。これらの技術は、肝臓、腎臓、心臓、肺、膵臓の保存に適用され、主に病院、移植センター、研究機関に提供されています。最終用途の範囲には、保存ソリューションを開発する専門研究所や、日常的な移植に重点を置く医療センターが含まれます。

臓器保存市場の主要成長要因としては、低体温マシン灌流のような保存技術の進歩、輸送中の臓器生存率の向上などが挙げられます。世界の臓器移植数の増加は、支持的な規制の枠組みと相まって、市場の成長をさらに後押ししています。さらに、保存期間の延長と転帰の改善に焦点を当てた研究イニシアチブの急増も大きく貢献しています。凍結保存と過冷却技術の開発には新たな潜在的機会が存在し、保存期間と品質を再定義することが期待されるため、投資と技術革新への注目が集まっています。企業がこれらを活用するためには、特に臓器輸送ロジスティクスの改良と携帯型灌流装置の開発において、研究機関との協力と研究開発への投資が推奨されます。

有望な成長にもかかわらず、臓器輸送におけるロジスティクスの問題や、先進的保存技術に関連する高コストといった課題が残っており、新興国市場での市場拡大を制限しています。さらに、規制遵守の複雑さが新規参入のハードルとなっています。革新的なセグメントは、侵襲性の低い灌流方法の改善と、保存中の臓器状態のリアルタイムモニタリングの強化にあります。市場は非常にダイナミックで、急速な技術進歩と個別化医療への推進が特徴です。企業は、競争上の優位性を維持し、進化する医療のニーズに効果的に対応するために、協調的パートナーシップと技術統合に注力すべきであり、市場課題に対処するために、持続可能性の目標や規制基準との整合性を確保する必要があります。

市場力学：急速に進化する臓器保存市場の主要市場洞察を公開

臓器保存市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 臓器移植手術件数の増加と多臓器不全の例
  • 臓器を即座に利用できる保存ソリューションに対する需要の高まり
  • 臓器提供に対する意識の高まり
• 市場抑制要因
  • 臓器保存技術に対する認知度の低さと経済的制約
• 市場機会
  • 改良された臓器保存手法とソリューションの研究開発の急成長
  • 臨床サービス提供の継続的拡大と在庫の拡大
• 市場課題
  • 人工臓器の入手可能性

ポーターのファイブフォース：臓器保存市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：臓器保存市場における外部からの影響の把握

外部マクロ環境要因は、臓器保存市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：臓器保存市場における競合情勢の把握

臓器保存市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：臓器保存市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臓器保存市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：臓器保存市場における成功への道筋を描く

臓器保存市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 臓器移植手術と多臓器不全の症例の増加
    • 臓器をすぐに利用できるようにするための保存ソリューションの需要が高まっている
    • 臓器提供に対する意識の継続的な高まり
  • 抑制要因
    • 臓器保存技術の認知度と経済性の制約が限られている
  • 機会
    • 改善された臓器保存方法とソリューションの研究開発の急速な成長
    • 臨床サービスの提供と在庫の拡大の継続
  • 課題
    • 人工臓器の入手可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 臓器保存市場：保存ソリューション別

• イントロダクション
• Celsior Solution
• Custodial HTK
• IGL-1 Solution
• Perfadex
• ウィスコンシン大学（UW）

第7章 臓器保存市場：臓器タイプ別

• イントロダクション
• 心臓
• 腎臓
• 肝臓
• 肺

第8章 臓器保存市場：技術別

• イントロダクション
• 酸素制御復温
• 体外機器灌流
• 低体温機器灌流
• 常温機器灌流
• 静的冷蔵保管

第9章 臓器保存市場：エンドユーザー別

• イントロダクション
• 病院
• 臓器移植センター
• 専門クリニック

第10章 南北アメリカの臓器保存市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の臓器保存市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの臓器保存市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • HRSA、臓器調達と移植ネットワーク近代化イニシアチブを発表
  • Paragonix Technologies、Signet Healthcareパートナー主導のシリーズBで2,400万米ドルを調達
  • Paragonix、移植用ドナー臓器をリアルタイムで追跡する総合デジタルプラットフォームを発表
  • バイオテクノロジー企業HEMARINAがHEMO2life技術でCEマークを取得
  • NHS Blood and Transplantが2,000万ポンドの調査ユニットを開始
  • OrganOxがOchre Bioとの提携を発表
  • 画期的なデバイス指定が付与されたLifecradle臓器保存システム
  • TransMedics、OCS DCD心臓適応症のFDA PMA承認を取得
  • FDAがバイオメディカルエンジニアリングと外科手術で開発された新しい臓器保存デバイスを承認
• 戦略分析と提言

企業一覧

• 21st Century Medicine
• Artivion, Inc.
• AVIONORD S.R.L.
• BioLife Solutions Inc.
• Bridge to Life Ltd.
• CARDIOLINK S.L.
• Carnamedica
• Dr. Franz Kohler Chemie GmbH
• EBERS MEDICAL TECHNOLOGY SL
• Essential Pharmaceuticals, LLC by Accord Healthcare Limited
• Global Transplant Solutions, Inc.
• Hemarina SA
• Institut Georges Lopez
• Lifeline Scientific, Inc.
• Organ Preservation Solutions Ltd.
• OrganOx Limited
• Paragonix Technologies, Inc.
• Preservation Solutions, Inc.
• S.A.L.F. S.p.A.
• Sandor Medicaids Pvt. Ltd.
• SAS Advanced Life Solutions
• ScubaTx Limited
• TransMedics, Inc.
• TX Innovations B.V.
• Vascular Perfusion Solutions, Inc.
• XVIVO AB

LIST OF FIGURES

• FIGURE 1. ORGAN PRESERVATION MARKET RESEARCH PROCESS
• FIGURE 2. ORGAN PRESERVATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ORGAN PRESERVATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ORGAN PRESERVATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ORGAN PRESERVATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ORGAN PRESERVATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ORGAN PRESERVATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ORGAN PRESERVATION MARKET DYNAMICS
• TABLE 7. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY CELSIOR SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY CUSTODIAL HTK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY IGL-1 SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY PERFADEX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY UNIVERSITY OF WISCONSIN (UW), BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY KIDNEYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY CONTROLLED OXYGENATED REWARMING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY EX VIVO MACHINE PERFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY HYPOTHERMIC MACHINE PERFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY NORMOTHERMIC MACHINE PERFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY STATIC COLD STORAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY ORGAN TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ORGAN PRESERVATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ORGAN PRESERVATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. CHINA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 64. CHINA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 65. CHINA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 66. CHINA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. INDIA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 68. INDIA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDIA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 70. INDIA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA ORGAN PRESERVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. ITALY ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 137. ITALY ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 138. ITALY ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 139. ITALY ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. POLAND ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 153. POLAND ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 154. POLAND ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 155. POLAND ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. QATAR ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 157. QATAR ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 158. QATAR ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 159. QATAR ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM ORGAN PRESERVATION MARKET SIZE, BY PRESERVATION SOLUTION, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM ORGAN PRESERVATION MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM ORGAN PRESERVATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM ORGAN PRESERVATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. ORGAN PRESERVATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 197. ORGAN PRESERVATION MARKET, FPNV POSITIONING MATRIX, 2023

The Organ Preservation Market was valued at USD 503.93 million in 2023, expected to reach USD 541.48 million in 2024, and is projected to grow at a CAGR of 7.72%, to USD 848.57 million by 2030.

Organ preservation refers to the set of medical practices designed to preserve organs between excision and transplantation, ensuring they remain viable for successful transplantation. The necessity of organ preservation stems from the critical demand-supply disparity in organ transplants, where timely and effective preservation techniques can enhance organ viability, potentially saving countless lives. These techniques are applied across liver, kidney, heart, lung, and pancreas preservation, serving primarily hospitals, transplant centers, and research institutions. The end-use scope includes specialized labs developing preservation solutions and medical centers focusing on routine transplants.

Key growth influencers in the organ preservation market include advancements in preservation technologies like hypothermic machine perfusion, improving organ viability during transportation. The increasing number of organ transplants globally coupled with supportive regulatory frameworks further propels market growth. Additionally, burgeoning research initiatives focusing on extending preservation times and improving outcomes contribute significantly. Emerging potential opportunities exist in the development of cryopreservation and supercooling techniques, promising to redefine preservation time frames and quality, thus attracting investment and innovation attention. For businesses to leverage these, collaboration with research institutions and investment in R&D are recommended, especially in refining organ transportation logistics and developing portable perfusion devices.

Despite the promising growth, challenges remain, like logistic issues in organ transport and the high costs associated with advanced preservation technologies, limiting market expansion in developing regions. Moreover, the complexity of regulatory compliance poses a hurdle for new entrants. Innovative areas lie in improving less invasive perfusion methods and enhancing real-time monitoring of organ conditions during preservation. The market is highly dynamic, characterized by rapid technological advancements and a push towards personalized medicine. Businesses should focus on collaborative partnerships and technology integration to maintain competitive advantages and meet evolving healthcare needs effectively, ensuring alignment with sustainability goals and regulatory standards to address market challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Preservation Market

The Organ Preservation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of organ transplantation surgeries and instances of the multi-organ failure
  • Growing demand for preserving solutions for immediate availability of the organ
  • Constant increase in the awareness of organ donation
• Market Restraints
  • Limited awareness and affordaboility constraints of organ preservation techniques
• Market Opportunities
  • Rapid growth in the R&D for improved organ preservation methods and solutions
  • Ongoing extension of clinical service offerings and inventory expansion
• Market Challenges
  • Availability of the artificial organs

Porter's Five Forces: A Strategic Tool for Navigating the Organ Preservation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Preservation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Preservation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Preservation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Preservation Market

A detailed market share analysis in the Organ Preservation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Preservation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Preservation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Organ Preservation Market

A strategic analysis of the Organ Preservation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Organ Preservation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, Artivion, Inc., AVIONORD S.R.L., BioLife Solutions Inc., Bridge to Life Ltd., CARDIOLINK S.L., Carnamedica, Dr. Franz Kohler Chemie GmbH, EBERS MEDICAL TECHNOLOGY SL, Essential Pharmaceuticals, LLC by Accord Healthcare Limited, Global Transplant Solutions, Inc., Hemarina SA, Institut Georges Lopez, Lifeline Scientific, Inc., Organ Preservation Solutions Ltd., OrganOx Limited, Paragonix Technologies, Inc., Preservation Solutions, Inc., S.A.L.F. S.p.A., Sandor Medicaids Pvt. Ltd., SAS Advanced Life Solutions, ScubaTx Limited, TransMedics, Inc., TX Innovations B.V., Vascular Perfusion Solutions, Inc., and XVIVO AB.

Market Segmentation & Coverage

This research report categorizes the Organ Preservation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Preservation Solution, market is studied across Celsior Solution, Custodial HTK, IGL-1 Solution, Perfadex, and University of Wisconsin (UW).
• Based on Organ Type, market is studied across Heart, Kidneys, Liver, and Lung.
• Based on Technique, market is studied across Controlled Oxygenated Rewarming, Ex vivo Machine Perfusion, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Static Cold Storage.
• Based on End-User, market is studied across Hospitals, Organ Transplant Centers, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of organ transplantation surgeries and instances of the multi-organ failure
    • 5.1.1.2. Growing demand for preserving solutions for immediate availability of the organ
    • 5.1.1.3. Constant increase in the awareness of organ donation
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and affordaboility constraints of organ preservation techniques
  • 5.1.3. Opportunities
    • 5.1.3.1. Rapid growth in the R&D for improved organ preservation methods and solutions
    • 5.1.3.2. Ongoing extension of clinical service offerings and inventory expansion
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of the artificial organs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Organ Preservation Market, by Preservation Solution

• 6.1. Introduction
• 6.2. Celsior Solution
• 6.3. Custodial HTK
• 6.4. IGL-1 Solution
• 6.5. Perfadex
• 6.6. University of Wisconsin (UW)

7. Organ Preservation Market, by Organ Type

• 7.1. Introduction
• 7.2. Heart
• 7.3. Kidneys
• 7.4. Liver
• 7.5. Lung

8. Organ Preservation Market, by Technique

• 8.1. Introduction
• 8.2. Controlled Oxygenated Rewarming
• 8.3. Ex vivo Machine Perfusion
• 8.4. Hypothermic Machine Perfusion
• 8.5. Normothermic Machine Perfusion
• 8.6. Static Cold Storage

9. Organ Preservation Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Organ Transplant Centers
• 9.4. Specialty Clinics

10. Americas Organ Preservation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Organ Preservation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Organ Preservation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. HRSA Announces Organ Procurement and Transplantation Network Modernization Initiative
  • 13.3.2. Paragonix Technologies Raises USD 24M in Series B Led by Signet Healthcare Partners
  • 13.3.3. Paragonix Launches Comprehensive Digital Platform for Real-Time Tracking of Donor Organs Destined for Transplantation
  • 13.3.4. The biotechnology company HEMARINA obtains the CE mark for its HEMO2life technology
  • 13.3.5. NHS Blood and Transplant launches pound 20 million research units
  • 13.3.6. OrganOx announces partnership with Ochre Bio
  • 13.3.7. Breakthrough device designation granted Lifecradle organ preservation system
  • 13.3.8. TransMedics Receives FDA PMA Approval of OCS DCD Heart Indication
  • 13.3.9. FDA approves novel organ preservation device developed across Biomedical Engineering and Surgery
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 21st Century Medicine
• 2. Artivion, Inc.
• 3. AVIONORD S.R.L.
• 4. BioLife Solutions Inc.
• 5. Bridge to Life Ltd.
• 6. CARDIOLINK S.L.
• 7. Carnamedica
• 8. Dr. Franz Kohler Chemie GmbH
• 9. EBERS MEDICAL TECHNOLOGY SL
• 10. Essential Pharmaceuticals, LLC by Accord Healthcare Limited
• 11. Global Transplant Solutions, Inc.
• 12. Hemarina SA
• 13. Institut Georges Lopez
• 14. Lifeline Scientific, Inc.
• 15. Organ Preservation Solutions Ltd.
• 16. OrganOx Limited
• 17. Paragonix Technologies, Inc.
• 18. Preservation Solutions, Inc.
• 19. S.A.L.F. S.p.A.
• 20. Sandor Medicaids Pvt. Ltd.
• 21. SAS Advanced Life Solutions
• 22. ScubaTx Limited
• 23. TransMedics, Inc.
• 24. TX Innovations B.V.
• 25. Vascular Perfusion Solutions, Inc.
• 26. XVIVO AB